Bacterial pathogens.
Bacterial infections are frequent complications among patients treated for cancer. The type, severity, and treatment of bacterial infections vary and depend upon the specific malignancy, associated chemotherapies, and transplantation. This chapter discusses commonly encountered bacterial pathogens as well as Nocardia and mycobacteria in patients with cancer and addresses the clinical syndromes and management. Drug-resistant bacteria are becoming an increasingly recognized problem in patients with cancer. Antimicrobial resistance in select gram-positive and gram-negative bacteria are discussed along with the mechanisms of resistance and recommended therapies.
Department of Medicine, Division of Infectious Diseases, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA, wilson.john@mayo.edu.
John W
JW
Wilson
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000472:pathogenicity*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000382:microbiology*; D012307:Risk Factors
D000900:Anti-Bacterial Agents